Syringes wand vials of the Pfizer-BioNTech Covid-19 vaccine are prepared to be administered to front-line health care workers under an emergency use authorization at a drive up vaccination site from Renown Health in Reno, Nevada on December 17, 2020. (Photo by Patrick T. Fallon / AFP) (Photo by PATRICK T. FALLON/AFP via Getty Images)

Pfizer-მა კორონავირუსის ვაქცინის მესამე ეტაპის კვლევა გააყალბა.

Pfizer-მა კორონავირუსის ვაქცინის მესამე ეტაპის კვლევა გააყალბა, რის შესახებაც FDA-ისთვისაც ცნობილი იყო. The Epoch Times-ის სტატიაზე დაყრდნობით ნათქვამია,რომ Pfizer-ის მიერ ვაქცინის კლინიკური კვლევისთვის დაქირავებულ ლაბორატორიებში კვლევის სტანდარტები და პროტოკოლი დარღვეული იყო, რაც ვაქცინის ხარისხსსა და უსაფრთხოებასთან დაკავშირებული მონაცემების სანდოობას კითხვის ნიშნის ქვეშ აყენებს. Alleged problems with a major clinical trial examining Pfizer’s COVID-19 vaccine are being probed, a contract company involved in the research has confirmed.

Ventavia Research Group operated several of the trial sites in the fall of 2020. Brook Jackson, who worked for the company during this time, told the British Medical Journal that the trial was riddled with issues, including the falsification of data.

Jackson said she alerted the Food and Drug Administration (FDA) to the problems she witnessed and was fired within hours.

Ventavia confirmed to The Epoch Times that it employed Jackson for two weeks last year. Lauren Foreman, director of business development and communications, said in an email that Ventavia is investigating Jackson’s allegations.

“Ventavia takes research compliance, data integrity, and participant safety very seriously and stands behind its important work supporting the development of lifesaving vaccines and is conducting its investigation accordingly,” she said.

The FDA appeared to confirm it was aware of the matter.